biomarkers

AZ outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC

AZ is using the biomarker in the phase 3 AVANZAR trial, which is evaluating Dato-DXd in combination with Imfinzi and chemo in first-line NSCLC.

Angus Liu Sep 8, 2024 12:22pm

Parkinsons

Pharma giants to take part in Parkinson’s biomarker project

Jul 17, 2024 4:18pm

Go sign green light

Ultragenyx gets green light to seek FDA approval of gene therapy

Jun 13, 2024 5:55am

Apple Watch Series 9

Apple Watch's AFib History certified by FDA for clinical studies

May 6, 2024 9:40am

doctor examining brain mri scans

Abbott advances its hand-held blood test for TBI, concussions

Apr 1, 2024 10:18am

blood test tube

Labcorp launches tri-biomarker Alzheimer's blood test

Oct 11, 2023 1:59pm